August 12, 2019, Monday
The company said that key points of the observations in Form 483 are the supplier and service provider agreements to be made more ...
July 15, 2019, Monday
Shares of Natco Pharma were trading 0.35 per cent higher at Rs 529.95 apiece on BSE
June 06, 2019, Thursday
The Food and Drug Administration's observations were procedural and "can be addressed within a short period of time", says Natco.
May 27, 2019, Monday
Natco Pharma revenues decreased by 38 per cent to Rs 486.7 crore in Q4, compared to Rs 787.9 crore in the year-ago period
February 21, 2019, Thursday
Lack of significant launch visibility has led analysts to estimate net profit numbers to be little changed next year
February 12, 2019, Tuesday
Margin reduction of Oseltamivir in the US market cited as the major cause for the decline in profits during the quarter
January 25, 2019, Friday
The decision marks Natco's first ever entry into agrochemical manufacturing, an all together a new area of business for a pharma ...
January 01, 2019, Tuesday
60-70% of the R&D spend will be for developing portfolio in Brazil, Canada, China & India
November 09, 2018, Friday
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period
November 08, 2018, Thursday
Domestic market has contributed a third of Natco Pharma's revenues of Rs 22 billion in 2017-18, though slipped in sales for the ...
